Abcam RabMAb recombinant rabbit monoclonal antibodies

Thursday, 12 October, 2017 | Supplied by: Abcam Australia Pty Ltd



Abcam has combined the advantages of its RabMAb rabbit monoclonals with recombinant technology to deliver high-performance antibodies. In order to provide users with antibodies that have good sensitivity and a high degree of consistency, the company has engineered recombinant versions of its RabMAb rabbit monoclonal antibodies, delivering a number of advantages.

Abcam currently offers over 10,000 recombinant RabMAb antibodies that provide low-background, high-specificity, high-affinity (10-12 kD possible) and diverse epitope recognition, with recombinant technology adding high consistency and reproducibility, improved specificity and animal-free production.

In addition to the benefits of recombinant RabMAb antibodies, Abcam validates each one in key applications (WB, IHC, ICC/IF, IP and flow cytometry) and species (human, mouse and rat). They are affinity purified to remove any impurities that could otherwise lead to non-specific signal.

Abcam provides over 3000 directly conjugated recombinant RabMAb antibodies, including popular dyes and enzymes. The company further includes knockout validation via CRISPR technology for a growing number of antibodies.

Online: www.abcam.com
Phone: 1800 024 968
Related Products

BioActs Fluorescent FSD Fluor Dyes

The FSD Fluor series is a panel of fluorescent dyes with good fluorescence intensity and a high...

Ansell BioClean PPE range

BioClean products are part of Ansell Limited's Life Sciences Solutions portfolio, offering a...

Larodan research-grade glycerides

Larodan develops a comprehensive range of research-grade lipids for use as analytical standards...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd